Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: KOSDAQ
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Celltrion Inc

+ Add to Watchlist

068270:KS

40,700 KRW 600 1.50%

As of 01:29:22 ET on 01/30/2015.

Snapshot for Celltrion Inc (068270)

Open: 40,750 Day's Range: 40,050 - 42,250 Volume: 1,228,557
Previous Close: 40,100 52wk Range: 35,476 - 50,286 1-Yr Rtn: -4.50%

Stock Chart for 068270

No chart data available.
  • 068270:KS 40,700
  • 1D
  • 1M
  • 1Y
40,100
Interactive 068270 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 068270

Current P/E Ratio (ttm) 43.8308
Estimated P/E(12/2014) -
Relative P/E vs. KOSPI 1.5114
Earnings Per Share (KRW) (ttm) 928.5714
Est. EPS (KRW) (12/2014) -
Est. PEG Ratio -
Market Cap (M KRW) 4,423,074.70
Shares Outstanding (M) 108.68
30 Day Average Volume 375,514
Price/Book (mrq) 3.5504
Price/Sale (ttm) 11.5478
Dividend Indicated Gross Yield -%
Cash Dividend (KRW) -
Dividend Ex-Date 12/27/2013
5 Year Dividend Growth -
Next Earnings Announcement 03/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 068270

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 068270

Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment.

Seo Jung-JinChairman/CEO/Rep DirectorPark Seong-DoVice Chairman
Hong Seung-SeoPresidentKim Yong-JikPresident
More Company Profile & Key Executives for 068270

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil